Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
傑柏思方案公司表示，它被富士製藥株式會社所選，以支持在北卡羅來納州霍利斯普林斯的一家端到端的大規模細胞培養合同製造基地的12億美元擴建。
Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina
傑柏思方案公司表示，它被富士製藥株式會社所選，以支持在北卡羅來納州霍利斯普林斯的一家端到端的大規模細胞培養合同製造基地的12億美元擴建。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。